TAG:
american association of clinical chemistry
Walgreens Tells Theranos: ‘Lab Deal Is Terminated’
By Robert Michel | From the Volume XXIII No. 8 – June 13, 2016 Issue
BREAKING NEWS: As this issue of THE DARK REPORT went to press, it was learned that Walgreens had announced the termination of its lab testing agreement with Theranos, effective immediately. Theranos loses access to about 40 Walgreens pharmacies in Phoe…
Is Theranos Kowtowing To CMS over Pending CLIA Sanctions?
By Robert Michel | From the Volume XXIII No. 7 – May 23, 2016 Issue
CEO SUMMARY: Having ignored the profession of laboratory medicine for nearly all of its 13-year corporate life, Theranos suddenly began engaging with expert laboratorians last month. The timing of this new outreach coincides with public disclosure that CMS proposed the severest sanctions …
Theranos CEO Elizabeth Holmes to Show Scientific Data at AACC Conference
By Joseph Burns | From the Volume XXIII No. 7 – May 23, 2016 Issue
CEO SUMMARY: Theranos Founder and CEO Elizabeth Holmes will be in Philadelphia to present to the American Association of Clinical Chemistry (AACC) data about the technology developed at Theranos. Conference organizers said Holmes would answer ques- tions to clarify the science, accuracy, …
AACC reveals details of its invitation to Theranos CEO
By Mary Van Doren | From the Volume XXIII No. 7 – May 23, 2016 Issue
This is an excerpt from a 925-word article in the May 23 issue of THE DARK REPORT. The complete article is available to paid members of the Dark Intelligence Group. …
Theranos Saga Just Keeps Getting More Intriguing
By Mary Van Doren | From the Volume XXIII No. 6 – May 2, 2016 Issue
This is an excerpt from a 400-word article in the May 2 issue of THE DARK REPORT. The complete article is available paid members of the Dark Intelligence Group. …
Theranos in the News, for Better and Worse
By R. Lewis Dark | From the Volume XXIII No. 6 – May 2, 2016 Issue
IT’S BEEN AN EVENTFUL COUPLE OF MONTHS for Theranos, the lab testing company that says its goal is to disrupt the clinical laboratory industry. Novelists cannot write fiction as compelling as the unfolding real story about this controversial company. During March and April, The Wall Street Jou…
Ignoring Lab Industry, Theranos Goes Its Way
By Robert Michel | From the Volume XXI No. 11 – August 11, 2014 Issue
CEO SUMMARY: With each passing month, Theranos pulls open the curtain a bit more on its business structure and its market growth plans. Its clinical lab tests are now offered in Walgreens pharmacies in Palo Alto, California, and Phoenix, Arizona. Recent news coverage in Fortune and USATod…
New ISO 15189 Book Published to Help Clinical Lab Managers
By Robert Michel | From the Volume XXI No. 5 – April 7, 2014 Issue
THERE IS NOW A COMPREHENSIVE GUIDE for lab executives and lab managers interested in learning more about ISO 15189:2012, the latest version of the quality management system (QMS) for medical laboratories. It is a book titled: “A Practical Guide to ISO 15189 in Laboratory Medicine” and was publis…
March 8, 2010 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XVII No. 4 – March 8, 2010 Issue
On March 1, Omnyx, LLC, of Pittsburgh, Pennsylvania, licensed certain virtual microscopy and digital pathology patents from Olympus America, Inc. Omnyx is a joint venture between GE Healthcare and the University of Pittsburgh Medical Center …
November 23, 2009 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XVI No. 16 – November 23, 2009 Issue
Identity theft was a key part of a financial fraud that Adeniyi Adeyemi, 27, used to steal approximately $1 million from accounts belonging to 11 not-for-profits and trusts. Among the victims was the American Association of Clinical Chemistry (AACC). Adeyemi was a computer technician…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized